West Pharmaceutical Services (WST) Revenue — Quarter Ended Sep 30, 2023
Revenue increased year-over-year but decreased slightly from the prior quarter. The company reported a year-over-year gain driven by higher sales volumes.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue increased year-over-year but decreased slightly from the prior quarter. The company reported a year-over-year gain driven by higher sales volumes.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$747.4M
Revenue reported for this quarter.
Quarter-over-quarter
-0.8%
Change from the immediately preceding quarter.
Year-over-year
+8.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $708.7M | -3.0% |
| Mar 31, 2023 | $716.6M | -0.5% |
| Jun 30, 2023 | $753.8M | -2.3% |
| Sep 30, 2023 | $747.4M | +8.8% |
Revenue performance
Net sales for the quarter were higher than the same period last year, reflecting continued demand for the company's products.
Quarterly comparison
Compared to the immediately preceding quarter, revenue saw a small decline, while compared to the same quarter one year earlier, revenue grew.
What to watch
Monitor whether the sequential revenue decline is a trend or a seasonal fluctuation.